|
|
|
|
|
by jhou2
2118 days ago
|
|
Well, I think they're trying to stimulate mucosal immunity, rather than trigger MHC presentation. But yes, more research is needed to determine effectiveness. "This highlights one important advantage of an intranasal
vaccine: a robust mucosal immune response should greatly reduce or prevent this
systemic response by abrogating initial infection." |
|